We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

For the first time, researchers have combined genetic testing with personalized drug screening directly on tumor samples to identify the right treatment for children with relapsed cancers. More...
12 Apr 2024
Image: Viable tumor cell density after neoadjuvant chemotherapy assessed using deep-learning model reflects prognosis of osteosarcoma (Photo courtesy of Kyushu University)

AI Detects Viable Tumor Cells for Accurate Bone Cancer Prognoses Post Chemotherapy

A new machine-learning model is capable of accurately evaluating the density of surviving tumor cells in osteosarcoma pathological images, offering a more reliable prognosis prediction. More...
05 Apr 2024
Image: The testing method could help some cancer patients to more effective treatment (Photo courtesy of 123RF)

Testing Method Could Help More Patients Receive Right Cancer Treatment

A new study points to a significant finding related to testing that could enable thousands of cancer patients to receive the precise treatment they need. More...
22 Mar 2024
Image: The DiaCarta RadTox Test is intended to offer an early assessment of patient response to treatment (Photo courtesy of DiaCarta)

Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients

A simple blood test monitors the concentration of circulating cell-free DNA in the bloodstream in real time to track how well a cancer treatment is working. More...
18 Mar 2024
Image: Streptococcus pyogenes in a petri dish (Photo courtesy of Imperial College London)

State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections

An international collaboration of scientists has established a comprehensive network to investigate the bacterial causes of sepsis and heart damage caused by the group A streptococcal (Strep A) bacteria. More...
23 Feb 2024
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome

A new pair of reagents can enable early diagnosis of antiphospholipid syndrome, an autoimmune disorder that typically presents as venous or arterial thrombosis and/or pregnancy loss. More...
22 Feb 2024
Image: The protein UCHL1 could lead to a new therapeutic approach for managing aggressive neuroendocrine carcinomas (Photo courtesy of Stoyanova, et al., doi.org/10.1016/j.xcrm.2023.101381)

New Protein Biomarker to Help Develop Blood-Based Tests for Aggressive Neuroendocrine Carcinomas

Researchers have identified a protein found in aggressive neuroendocrine carcinomas and neuroblastoma as a potential molecular biomarker for diagnosing these cancers and predicting and monitoring therapy responses. More...
16 Feb 2024
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.
Copyright © 2000-2024 Globetech Media. All rights reserved.